Skip to content
No results
  • About Us
  • Contact Us
  • Disclaimer
  • Event Venues
  • Events and Conferences
  • Home
  • Organizer Dashboard
  • Organizer Dashboard
  • Privacy Policy
  • Submit Organizer Form
  • Submit Organizer Form
  • Submit Venue Form
  • Submit Venue Form
  • Subscribe
  • Terms and Conditions
  • Venue Dashboard
  • Venue Dashboard
  • About Us
  • Contact Us
The Pharma Data

  • News
  • Press Releases
  • Research
  • Business
  • Regulatory
  • Events and Conferences
The Pharma Data
  • Research

Etcembly and University of Surrey Launch Study on Next-Gen Cancer Treatments from Survivors

  • The Pharma Data
  • October 17, 2024

Etcembly and University of Surrey Launch Study to Transform Cancer Treatment British techbio innovator Etcembly is collaborating with researchers from the University of Surrey to launch a groundbreaking study aimed…

Read MoreEtcembly and University of Surrey Launch Study on Next-Gen Cancer Treatments from Survivors
  • Research

Merck’s CAPVAXIVE™ Vaccine Shows Positive Immune Response in Adults at Risk for Pneumococcal Disease

  • The Pharma Data
  • October 17, 2024

STRIDE-8 Study Results Highlight CAPVAXIVE’s Efficacy in Pneumococcal Disease Prevention CAPVAXIVE Demonstrates Strong Immune Response and Coverage Against Major Serotypes RAHWAY, N.J. — Merck (NYSE: MRK), known as MSD outside…

Read MoreMerck’s CAPVAXIVE™ Vaccine Shows Positive Immune Response in Adults at Risk for Pneumococcal Disease
  • Research

ViiV Healthcare Reports Over 99% Effectiveness for Apretude in Real-World Studies at IDWeek 2024

  • The Pharma Data
  • October 17, 2024

ViiV Healthcare Presents Real-World Evidence for Apretude (Cabotegravir Long-Acting) at IDWeek 2024 GSK plc (LSE/NYSE: GSK) has announced that ViiV Healthcare, a global leader in HIV treatment and prevention, has…

Read MoreViiV Healthcare Reports Over 99% Effectiveness for Apretude in Real-World Studies at IDWeek 2024
  • Regulatory

FDA Grants Priority Review for Gepotidacin to Treat Uncomplicated UTIs in Women and Adolescents

  • The Pharma Data
  • October 17, 2024

GSK’s Gepotidacin Accepted for FDA Priority Review to Treat Uncomplicated UTIs GSK plc (LSE/NYSE: GSK) has announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug…

Read MoreFDA Grants Priority Review for Gepotidacin to Treat Uncomplicated UTIs in Women and Adolescents
  • Research

Bayer to Showcase New Research on Menopause Symptoms at IMS 2024

  • The Pharma Data
  • October 17, 2024

Bayer to Present Latest Research on Menopausal Sleep Disturbances at IMS 2024 Bayer is set to showcase its latest research on menopause symptoms, particularly sleep disturbances, at the 19th World…

Read MoreBayer to Showcase New Research on Menopause Symptoms at IMS 2024
  • Press Releases

Woman’s Brain Foundation and Medscape Education Launch Centre on Sex, Gender, and the Brain

  • The Pharma Data
  • October 17, 2024

The Women’s Brain Foundation and Medscape Education Launch Learning Center on Sex and Gender in Brain Health The Women’s Brain Foundation (WBF), a leader in integrating sex- and gender-based research…

Read MoreWoman’s Brain Foundation and Medscape Education Launch Centre on Sex, Gender, and the Brain
  • Press Releases

Sensorion to Present GJB2-GT at European Society of Gene and Cell Therapy Congress

  • The Pharma Data
  • October 17, 2024

Sensorion to Present GJB2-GT Research at ESGCT Congress 2024 Sensorion (FR0012596468 – ALSEN), a pioneering clinical-stage biotechnology company specializing in the development of innovative therapies for hearing loss, has announced…

Read MoreSensorion to Present GJB2-GT at European Society of Gene and Cell Therapy Congress
  • Research

GenSight Biologics Unveils LUMEVOQ® Scientific Updates at AAO 2024

  • The Pharma Data
  • October 17, 2024

GenSight Biologics Announces LUMEVOQ® Scientific Updates at AAO 2024 GenSight Biologics (Euronext: SIGHT), a biopharmaceutical company specializing in innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders,…

Read MoreGenSight Biologics Unveils LUMEVOQ® Scientific Updates at AAO 2024
  • News

Verastem Oncology Highlights RAMP 201 Data for Avutometinib and Defactinib in Ovarian Cancer at IGCS 2024

  • The Pharma Data
  • October 17, 2024

Verastem Oncology Reports Promising RAMP 201 Data for Avutometinib and Defactinib in Low-Grade Serous Ovarian Cancer Verastem Oncology has announced encouraging results from its Phase 2 RAMP 201 trial, showcasing…

Read MoreVerastem Oncology Highlights RAMP 201 Data for Avutometinib and Defactinib in Ovarian Cancer at IGCS 2024
  • Business

Horizon Surgical Systems Secures $30 Million in Series A Funding

  • The Pharma Data
  • October 17, 2024

ExSight Ventures Leads $30 Million Financing Round to Propel Development of the Polaris System for Eye Surgery Horizon Surgical Systems, a pioneering company specializing in micro-robotics for eye surgery, has…

Read MoreHorizon Surgical Systems Secures $30 Million in Series A Funding
  • News

New Study Shows Significant Decline in Life Expectancy Improvements

  • The Pharma Data
  • October 17, 2024

Lapetus Solutions Advocates for Shift from Disease Focus to Aging and Healthy Life Extension A recent paper published in Nature Aging, titled “Implausibility of Radical Life Extension in Humans in…

Read MoreNew Study Shows Significant Decline in Life Expectancy Improvements
  • Press Releases

FoodMinds Launches 2024 Global Report on Conscious Consumption Index

  • The Pharma Data
  • October 17, 2024

Insights on Consumer Attitudes Toward Healthy, Sustainable Food Systems The FoodMinds 2024 Conscious Consumption Index (CCI) reveals a growing awareness of healthy and sustainable food systems among consumers. Despite this…

Read MoreFoodMinds Launches 2024 Global Report on Conscious Consumption Index
PrevNext
UK Biotech Day
Global Clinical Trial Supply Forum 2026 I Frankfurt, Germany
Global Clinical

About

The Pharma Data is an Information-Centric Website focused mainly on the Pharmaceutical Industry Online It is a B2B Platform mainly focused on the latest Pharmaceutical News, Press releases, Industry-related updates, Events, and Conferences. With The Pharma Data, you can get all the information that happening in the Pharmaceutical industry.

Advertise With Us: marketing@thepharmadata.com

Latest Posts

  • Bepirovirsen Gains European Medicines Agency Review as a Potential First-in-Class Therapy for Chronic Hepatitis B
  • Novartis to Acquire Excellergy, Inc., Strengthening Allergy Leadership with Next-Generation Anti-IgE Innovation
  • AbbVie to Present New Data Advancing Care in Immune-Mediated Skin Diseases at AAD 2026
  • About Us
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Contact Us

Copyright © 2026 | The Pharma Data | Marnet Technologies Pvt Ltd | All Rights Reserved.